Dylan Bennett

Dylan Bennett currently serves as the Area Sales Manager at CSL, focusing on Rare Disease products related to Hereditary Angioedema and Anticoagulation Reversal since January 2020. Prior experience includes roles as an Executive Cardiovascular Sales Specialist at Novartis, where a novel neprilysin inhibitor for systolic Heart Failure was marketed, and as a Hospital Cardiovascular Sales Specialist at AstraZeneca, promoting medications for Dyslipidemia and Acute Coronary Syndrome in Los Angeles. Additional experience encompasses a progression at Merck from a Primary Care Sales Representative to a Cardiovascular Scientific Liaison, along with an early role as an Associate Scientist at Miravant Medical. Educational qualifications include a B.S. in Pharmacology from UC Santa Barbara and an MBA from the University of Redlands.